Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search

We found 6,273 results for "Marketing the Law Firm"...

<b>Technology in Marketing:</b> Podcasting For Lawyers: The Nuts And Bolts
February 28, 2006
In layman's terms, podcasting provides publishers with the ability to create their own audio broadcast and store it on the Internet for download by interested individuals to listen to at any time ' and anywhere ' they want. <br>This article will explain the nuts and bolts of creating a "podcast."
<b>The Place to Network:</b> Mind Over Matter
February 28, 2006
Visualization can help speed the process of learning a new skill ' networking, for instance. My coaching clients' main priority is often increasing their level of confidence and comfort in networking. They want to feel absolutely confident when walking into a room full of strangers at a cocktail party, or when going onstage to face a sea of people at a conference. They want to feel perfectly at ease, and perform at their best, when meeting a new client, or current clients ' especially someone who they know to be difficult. Visualization is a perfect tool for this: through guided imagery, you can ensure that whatever you're feeling is exactly those feelings you want; and that you're performing at the top of your abilities. Visualized behaviors can be practiced more easily, quickly and frequently than actual behaviors, so they're an ideal complement to actual, practice.
A Regulatory Lawyer's Perspective: The FDA's Guidances on Risk Assessment, Minimization and Management
February 28, 2006
In the pharmaceutical industry, due to all types of business pressures and constraints, it is not atypical for a company to behave reactively and in triage-mode, rather than considering proactive steps that it can take in the compliance arena. In 2005, the Food and Drug Administration ("FDA") issued three final guidance documents to help focus the industry and encourage companies to consider more thoughtfully and thoroughly the issues of quality risk assessment, minimization, and management collectively.
Protecting E-mail For Complete Client Privacy
February 28, 2006
Attorney-client privilege, liability for breach of confidentiality obligations and damage to a firm's reputation were all reasons originally cited for stopping the use of e-mail at law firms before it even started. Convenience and responsiveness to clients became justification enough to ignore the basic issue that e-mail was inherently insecure. The standard form disclaimer that we now see at the end of every lawyer's e-mail became the solution to protecting the confidential nature of attorney-client communications. Is it sufficient today?
Lawyers Recruiting Mock Juries on the Net
February 28, 2006
After months of preparation, the lawyers at Sanders, Simpson &amp; Fletcher had their case almost ready for trial. The Springfield, MO, plaintiffs' firm of 11 lawyers had worked hard to fine-tune the civil case. Their client had the potential of being awarded significant damages. But the allegation -- sexual misconduct against a church pastor -- was tricky. Would the facts of the case resonate well with jurors?
Lessons from the First Vioxx Verdict
February 28, 2006
What do you get when you cross Court TV with the Food Channel? One answer: a recipe for a multi-million dollar jury verdict! Drug giant Merck will not see such blended TV programming, but it may have seen stars after getting hit with a $253 million jury award on Aug. 19, 2005. The first product liability trial against its Cox-2 inhibitor drug Vioxx in Angleton, TX, in August, 2005 produced a quarter-billion dollar award, $229 million of which was for punitive damages. Merck plans a vigorous appeal on multiple grounds. (Reportedly, grounds for appeal include: 1) letting in testimony from unqualified experts; 2) letting in testimony not based on reliable scientific evidence; 3) allowing irrelevant but prejudicial evidence in against Merck; and 4) letting in an undisclosed "surprise" witness against Merck.) Even pro-plaintiff observers concede that the award will likely drop to "only" $26 million due to recent Texas tort reform caps on punitive damages. (Merck fared better in its second and third Vioxx trials, which ended with a defense verdict and hung jury, respectively. Three Vioxx cases down -- only about 5998 to go!)
Drug & Device News
February 28, 2006
The latest news you need to know.
Another Kind Of Room With A View
February 28, 2006
Ramping up for document-review is a challenging prospect, requiring a firm to react quickly and aggressively, depending on the requirements of the case. The timeline for reviews can be extremely long, requiring attorneys to spend months sifting through information or very short, at times requiring firms to use contract attorneys to scale up to several times their original staffs' size to meet deadlines. <br>Vendors are offering off-site document-review rooms (DRRs) more frequently for customers who see the value these resources provide, and the DRR market is expanding.
Business Crimes Hotline
February 27, 2006
National cases of interest to you and your practice.
Compensation Decision Aids: How Better Guidance Evolved
February 27, 2006
When I began consulting 18 years ago, compensation advisory services focused primarily on benchmarking. We would look at market data, find comparables, refine study data to adjust for timing differences, and determine appropriate compensation ranges. This latter focus was partly due to the nationwide run-up in associate starting salaries and law firms' attempts to deal with those market forces and the system-wide compression they created.

MOST POPULAR STORIES

  • The Article 8 Opt In
    The Article 8 opt-in election adds an additional layer of complexity to the already labyrinthine rules governing perfection of security interests under the UCC. A lender that is unaware of the nuances created by the opt in (may find its security interest vulnerable to being primed by another party that has taken steps to perfect in a superior manner under the circumstances.
    Read More ›
  • The Anti-Assignment Override Provisions
    UCC Sections 9406(d) and 9408(a) are one of the most powerful, yet least understood, sections of the Uniform Commercial Code. On their face, they appear to override anti-assignment provisions in agreements that would limit the grant of a security interest. But do these sections really work?
    Read More ›
  • Chambers & Partners: What's New After Sale
    On Nov. 10, 2023, Abry Partners, a leading North American middle market private equity firm, announced that it had acquired Chambers & Partners for $449 million from Inflexion, the UK private equity firm that purchased Chambers in 2018. What will this mean?
    Read More ›
  • Strategy vs. Tactics: Two Sides of a Difficult Coin
    With each successive large-scale cyber attack, it is slowly becoming clear that ransomware attacks are targeting the critical infrastructure of the most powerful country on the planet. Understanding the strategy, and tactics of our opponents, as well as the strategy and the tactics we implement as a response are vital to victory.
    Read More ›
  • Major Differences In UK, U.S. Copyright Laws
    This article highlights how copyright law in the United Kingdom differs from U.S. copyright law, and points out differences that may be crucial to entertainment and media businesses familiar with U.S law that are interested in operating in the United Kingdom or under UK law. The article also briefly addresses contrasts in UK and U.S. trademark law.
    Read More ›